Ausgabe 1/2023
Inhalt (97 Artikel)
Clinical and economic benefits of image-guided system in functional endoscopicsinus surgery: a retrospective chart review study in China
Zaixing Wang, Chunling Liu, Baoying Tan, Guoqing Sun, Poucheok Pang, Kangchen lv, Hui Xie, Xiong Ou, Xianhai Zeng, Jianwei Xuan
Quantifying the direct cost benefits of vestibular telemetry using the CAVA system to diagnose the causes of dizziness
John S Phillips, Jacob Newman
One-stage vs two-stage bilateral THA in Lombardy: a cost-effectiveness analysis
Pierluigi Pironti, Andrea Ambrosanio, Valeria Vismara, Marco Viganò, Eugenia Bucci, Paolo Sirtori, Giuseppe M Peretti, Laura Mangiavini
Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer
Fernando Henrique de Albuquerque Maia, Luciana Martins Rozman, Heloisa de Andrade Carvalho, Patrícia Coelho de Soárez
Direct and indirect medical costs of bladder cancer in Iran
Mehdi Raadabadi, Rajabali Daroudi, Kazem Zendehdel, Ali Akbar Haghdoost, Mohammad Reza Ebadzadeh, Hamideh Rashidian
Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain
Dolores Isla, Marta Lopez-Brea, María Espinosa, Natalia Arrabal, Diego Pérez-Parente, David Carcedo, Reyes Bernabé-Caro
Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in “Boao Lecheng Pilot Zone”
Jiahe Li, Lichang Liu, Haijun Cao, Mei Yang, Xin Sun
Healthcare costs of congenital cytomegalovirus (cCMV) disease in infants during the first two years of life: a retrospective German claims database analysis
Anna-Janina Stephan, Marion de Lepper, Regine Wölle, Agnes Luzak, Wei Wang, Christian Jacob, Kim Maren Schneider, Horst Buxmann, Rangmar Goelz, Klaus Hamprecht, Peter Kummer, Susanne Modrow, Wolfgang Greiner, Miriam Reuschenbach
Correction: One-stage vs two-stage bilateral THA in Lombardy: a cost-effectiveness analysis
Pierluigi Pironti, Andrea Ambrosanio, Valeria Vismara, Marco Viganò, Eugenia Bucci, Paolo Sirtori, Giuseppe M. Peretti, Laura Mangiavini
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma: a systematic review and meta-analysis
Zahra Goudarzi, Mehrdad Mostafavi, Mahmood Salesi, Mojtaba Jafari, Iman Mirian, Amir Hashemi Meshkini, Khosro Keshavarz, Younes Ghasemi
Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review
Yat Hang To, Peter Gibbs, Jeanne Tie, Maarten IJzerman, Koen Degeling
Cost-effectiveness of seven-days-per-week rehabilitation schedule for acute stroke patients
Yasuhiro Morii, Kagari Abiko, Toshiya Osanai, Jiro Takami, Takumi Tanikawa, Kensuke Fujiwara, Kiyohiro Houkin, Katsuhiko Ogasawara
Cost effectiveness of home care versus hospital care: a retrospective analysis
Iris Megido, Yael Sela, Keren Grinberg
Economic costs, health-related quality of life outcomes and cost-utility of a physical and psychological group intervention targeted at older adults with neurogenic claudication
Mandy Maredza, Kamran Khan, Ioana R. Marian, Susan J. Dutton, Esther Williamson, Sarah E. Lamb, Stavros Petrou
Essential emergency and critical care as a health system response to critical illness and the COVID19 pandemic: what does it cost?
Lorna Guinness, Angela Kairu, August Kuwawenaruwa, Karima Khalid, Khamis Awadh, Vincent Were, Edwine Barasa, Hiral Shah, Peter Baker, Carl Otto Schell, Tim Baker
Cost-effectiveness analysis of coronary arteries bypass grafting (CABG) and percutaneous coronary intervention (PCI) through drug stent in iran: a comparative study
NourolHoda Fakhrzad, Mohsen Barouni, Reza Goudarzi, Javad Kojuri, Yunes Jahani, Mohammad Tasavon Gholamhoseini
COVID-19 versus applied infection control policies in a Major Transplant Center in Iran
Mojtaba Shafiekhani, Tahmoores Niknam, Seyed Ahmad Tara, Parviz Mardani, Khatereh Mirzad Jahromi, Sedigheh Jafarian, Sara Arabsheybani, Halimeh Negahban, Majid Hamzehnejadi, Zahra Zare, Khadijeh Ghaedi Ghalini, Ali Ghasemnezhad, Mahmoud Akbari, Reza Shahriarirad, Seyed Ali MalekHosseini
Excess healthcare costs of mental disorders in children, adolescents and young adults in the Basque population registry adjusted for socioeconomic status and sex
Igor Larrañaga, Oliver Ibarrondo, Lorea Mar-Barrutia, Myriam Soto-Gordoa, Javier Mar
Cost-effectiveness analysis of adding durvalumab to chemotherapy as first-line treatment for advanced biliary tract cancer based on the TOPAZ-1 trial
Qiuling Zhao, Ruixiang Xie, Wanfu Zhong, Wenbin Liu, Ting Chen, Xiuliang Qiu, Lin Yang
Cost-effectiveness analysis of sorafenib, lenvatinib, atezolizumab plus bevacizumab and sintilimab plus bevacizumab for the treatment of advanced hepatocellular carcinoma in China
Hongyu Gong, Siew Chin Ong, Fan Li, Zhiying Weng, Keying Zhao, Zhengyou Jiang
Cost-effectiveness of COVID-19 vaccination in Latin America and the Caribbean: an analysis in Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru
Federico Augustovski, Ariel Bardach, Adrián Santoro, Federico Rodriguez-Cairoli, Alejandro López-Osornio, Fernando Argento, Maissa Havela, Alejandro Blumenfeld, Jamile Ballivian, Germán Solioz, Analía Capula, Analía López, Cintia Cejas, William Savedoff, Alfredo Palacios, Adolfo Rubinstein, Andrés Pichon-Riviere
Monetary valuation of COVID-19 informal care: caregivers’ willingness to pay and willingness to accept
Vajiheh Ramezani-Doroh, Faride Karimi, Maryam Rangchian, Yadolah Hamidi
Cost-utility of vitamin D supplementation to prevent acute respiratory infections in children
Jefferson Antonio Buendía, Diana Guerrero Patiño
Correction to: Economic costs, health-related quality of life outcomes and cost-utility of a physical and psychological group intervention targeted at older adults with neurogenic claudication
Mandy Maredza, Kamran Khan, Ioana R. Marian, Susan J. Dutton, Esther Williamson, Sarah E. Lamb, Stavros Petrou
Associations between treatment burden, self-reported treatment qualities, antiretroviral therapy obtainment, and health-related quality of life among Ugandan PLWH
Ming Guan, Hongyi Guan
Healthcare reform and productivity of Hospital: a DEA-based analysis from South West of Iran
Sajad Vahedi, Mansour Zahiri, Narges Pirani, Amin Torabipour
Systematic review of economic evaluations for paediatric pulmonary diseases
Mutsawashe Chitando, Susan Cleary, Lucy Cunnama
Cost-effectiveness of surgical treatment of thumb carpometacarpal joint arthritis: a value of information study
Alfred P. Yoon, David W. Hutton, Kevin C. Chung
Health and economic outcomes of a universal early intervention for parents and children from birth to age five: evaluation of the Salut Programme using a natural experiment
Filipa Sampaio, Jenny Häggström, Richard Ssegonja, Eva Eurenius, Anneli Ivarsson, Anni-Maria Pulkki-Brännström, Inna Feldman
The FLURESP European commission project: cost-effectiveness assessment of ten public health measures against influenza in Italy: is there an interest in COVID-19 pandemic?
Ariel Beresniak, Christian Napoli, John Oxford, Alejandra Daruich, Laurent Niddam, Gérard Duru, Alberto E. Tozzi, Marta Ciofi degli Atti, Danielle Dupont, Caterina Rizzo, Dominique Bremond-Gignac
What are economic costs and when should they be used in health economic studies?
Hugo C. Turner, Frank G. Sandmann, Laura E. Downey, Stacey Orangi, Yot Teerawattananon, Anna Vassall, Mark Jit
Assessment of equity and efficiency of magnetic resonance imaging services in Henan Province, China
Xiaoling Huang, Yan Wei, Hui Sun, Jiaqi Huang, Yingyao Chen, Jingliang Cheng
Cost of image-guided percutaneous nephrostomy among cervical cancer patients at Muhimbili National Hospital in Tanzania
Amani Thomas Mori, Cecilia J. Nyabakari
A cost-effectiveness analysis of ruxolitinib versus best alternative therapy for patients with steroid-refractory chronic graft-versus-host disease aged > 12 years in Singapore
Jian Chun Matthew Ong, Hein Than, Sandeep Tripathi, Christina Gkitzia, Xiaojun Wang
Generic drug crisis in Japan and changes leading to the collapse of universal health insurance established in 1961: the case of Kobayashi Kako Co. Ltd.
Makoto Kosaka, Akihiko Ozaki, Yudai Kaneda, Hiroaki Saito, Erika Yamashita, Anju Murayama, Hanano Mamada, Tetsuya Tanimoto, Mihajlo Jakovljevic
Budget impact analysis of a digital monitoring platform for COPD
Timothy J. Inocencio, Kimberly L. Sterling, Sibel Sayiner, Michael E. Minshall, Leanne Kaye, Umur Hatipoğlu
Estimation of the value of curative therapies in oncology: a willingness-to-pay study in China
Li Huang, Xiaochen Peng, Lihua Sun, Dawei Zhang
Exploration of an alternative reconstructed individual patient data-based approach for budget impact analysis of anticancer drugs
Yue Ma, Jiting Zhou, Yuxin Ye, Aixia Ma, Hongchao Li
Could high continuity of care (COC) have a negative impact on subjective health of hypertensive patients? A Japanese perspective
Narimasa Kumagai, Shuzo Nishimura, Mihajlo Jakovljević
A cost-effectiveness analysis of COVID-19 critical care interventions in Addis Ababa, Ethiopia: a modeling study
Senait Alemayehu Beshah, Arega Zeru, Wogayehu Tadele, Atkure Defar, Theodros Getachew, Lelisa Fekadu Assebe
Impact of a diabetes pay-for-performance program on nonincentivized mental disorders: a panel study based on claims database analysis
Ming-Chan Sung, Kuo-Piao Chung, Shou-Hsia Cheng
Cost-utility analysis of genomic profiling in early breast cancer in Colombia
Leonardo Rojas, María X. Rojas-Reyes, Diego Rosselli, Juan Guillermo Ariza, Alejandro Ruiz-Patiño, Andrés F. Cardona
Healthcare costs for hospitalized COVID-19 patients in a Japanese university hospital: a cross-sectional study
Shunsuke Uno, Rei Goto, Kimiko Honda, Machiko Tokuda, Hirofumi Kamata, Shotaro Chubachi, Ryo Yamamoto, Yukio Sato, Koichiro Homma, Sho Uchida, Ho Namkoong, Yoshifumi Uwamino, Junichi Sasaki, Koichi Fukunaga, Naoki Hasegawa
Heterogeneity in health funding and disparities in health outcome: a comparison between high focus and non-high focus states in India
Ranjan Kumar Mohanty, Deepak Kumar Behera
Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran
Zahra Goudarzi, Fattaneh Danayi, Khosro Keshavarz, Ahmad Gholami
Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer
Hui Sun, Huishan Wang, Yan Wei, Haiyin Wang, Chunlin Jin, Yingyao Chen
Lymphedema self-care: economic cost savings and opportunities to improve adherence
Pinar Karaca-Mandic, Craig A. Solid, Jane M. Armer, Roman Skoracki, Elizabeth Campione, Stanley G. Rockson
INES: Interactive tool for construction and extrapolation of partitioned survival models
Vicente Gimeno-Ballester, Daniel Perez-Troncoso, Antonio Olry-Labry, David Epstein
Costs of fall injuries in the STRIDE study: an economic evaluation of healthcare system heterogeneity and heterogeneity of treatment effect
David A. Ganz, Thomas M. Gill, David B. Reuben, Shalender Bhasin, Nancy K. Latham, Peter Peduzzi, Erich J. Greene
Overview of the main methods used for estimating catastrophic health expenditure
Huyen Anh Nguyen, Sayem Ahmed, Hugo C. Turner
Is Aducanumab treatment developed to prevent progression of Alzheimer's disease cost-effective in Turkey?
Vahit Yigit, Selin Kalender, Iskender Cetinturk
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting
Mikkelsen Malene B, Husby Oyvind, Molden Tor, Mwaura David N, Olsen Jens, Kristensen Nanna V, Vietri Jeffrey
Application of a cost calculation approach in medical oncology: case of Hassan II university hospital in Morocco
A. Benabdallah, T. Jellouli
The impact of government subsidy programs on equity in health financing
Yousef Mohammadzadeh, Aysan Sheikhmali, Jafar Yahyavi Dizaj, Ali Mohammad Mosadeghrad, Hasan Yusefzadeh, Arash Refah Kahriz
Assessing the impact of grief on quality of life, work productivity, and health outcomes for parents bereaved from SMA: A study protocol
Abigail G. Riley, Christina M. Mulé, Debra Lerner, Lisa Belter, Colleen McCarthy O’Toole, Stacey Kowal, David Fox, Sheila Shapouri, Tamara Vesel, Tara A. Lavelle
Publisher Correction: cost-effectiveness of COVID-19 vaccination in Latin America and the Caribbean: an analysis in Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru
Federico Augustovski, Ariel Bardach, Adrián Santoro, Federico Rodriguez-Cairoli, Alejandro López-Osornio, Fernando Argento, Maissa Havela, Alejandro Blumenfeld, Jamile Ballivian, Germán Solioz, Analía Capula, Analía López, Cintia Cejas, William Savedoff, Alfredo Palacios, Adolfo Rubinstein, Andrés Pichon-Riviere
Economic evaluations of non-communicable diseases conducted in Sub-Saharan Africa: a critical review of data sources
Samantha A Hollingworth, Glory-Anne Leaupepe, Justice Nonvignon, Ama Pokuaa Fenny, Emmanuel A. Odame, Francis Ruiz
Economic burden of breast cancer: a case of Southern Iran
Faride Sadat Jalali, Khosro Keshavarz, Mozhgan Seif, Majid Akrami, Abdosaleh Jafari, Ramin Ravangard
Successes and challenges of China’s health care reform: a four-decade perspective spanning 1985—2023
Mihajlo Jakovljevic, Hanyu Chang, Jay Pan, Chao Guo, Jin Hui, Hao Hu, Danko Grujic, Zhong Li, Lizheng Shi
Cost-effectiveness analysis of robot-assisted gait training in patients with bilateral spastic cerebral palsy
Stanislava Klobucká, Robert Klobucký, Katarína Valovičová, Pavol Šiarnik, Branislav Kollár
Cost-effectiveness of pemigatinib as a second-line treatment for advanced intrahepatic cholangiocarcinoma with fibroblast growth factor receptor 2 fusions in Taiwan: from the evidence of the phase II trial and the perspective of Taiwan's National Health Insurance Administration
Zi-Rong Chen, Chen-Han Chueh, Nai-Jung Chiang, Yi-Wen Tsai
Framework for determining the optimal course of action when efficiency and affordability measures differ by perspective in cost-effectiveness analysis—with an illustrative case of HIV treatment in Mozambique
Joseph Corlis, Jinyi Zhu, Hélder Macul, Orrin Tiberi, Makini A. S. Boothe, Stephen C. Resch
Operative vs. conservative treatment of AC-Joint Dislocations Rockwood grade ≥ III -An economical and clinical evaluation-
Richard Niehaus, Alisa Schleicher, Elias Ammann, Philipp Kriechling, Christopher G. Lenz, Michael Masanneck, Sandro Hodel, Karim Eid
Cost-effectiveness analysis of COVID-19 tests in the unified health system
Vinicius Queiroz Miranda Cedro, Stéfany de Lima Gomes, Ana Clara Correa Duarte Simões, Tatiana do Valle Lovato Sverzut, Keila Cristina Xavier Bertti, Marcelo Tadeu Tristão, Yuri Wanderley Cavalcanti, João Victor Frazão Câmara, Antonio Carlos Pereira
Nivolumab plus chemotherapy versus chemotherapy alone as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: a cost-effectiveness analysis
Peng-Fei Zhang, Xuan-Qiong Shi, Qiu Li
Cost minimization in breast conserving surgery: a comparative study of radiofrequency spectroscopy and full cavity shave margins
Richard Gilmore, Jennifer Chen, Robert Dembinski, Yannis Reissis, David Milek, Lisa Cadena, Mehran Habibi
Implementation of a vascular access specialist team in a tertiary hospital: a cost-benefit analysis
Laura Ricou Ríos, Candela Esposito Català, Arnau Pons Calsapeu, Cristina Adroher Mas, Isabel Andrés Martínez, Isaac Nuño Ruiz, Mònica Castellà Creus, Laia Castellà Fàbregas, Maria José García Quesada, Oriol Estrada Cuxart, Jordi Ara del Rey, Francesc López Seguí
Tuberculosis prevention, diagnosis, and treatment financial profile during 2006–2021: PART A
Maryam Meskini, Nahid Madadi, Kamal Ahmadi, Farzam Vaziri, Abolfazl Fateh, Seyed Davar Siadat
The health and economic impact and cost effectiveness of interventions for the prevention and control of overweight and obesity in Kenya: a stakeholder engaged modelling study
Mary Njeri Wanjau, Lucy W. Kivuti-Bitok, Leopold N. Aminde, J. Lennert Veerman
Measuring efficiency of public hospitals under the impact of Covid-19: the case of Türkiye
Seher Nur Sülkü, Alper Mortaş, Aziz Küçük
Correction: Economic burden of breast cancer: a case of Southern Iran
Faride Sadat Jalali, Khosro Keshavarz, Mozhgan Seif, Majid Akrami, Abdosaleh Jafari, Ramin Ravangard
Cost-effectiveness thresholds or decision-making threshold: a novel perspective
Lihua Sun, Xiaochen Peng, Shiqi Li, Zhe Huang
Loss ratio of the capitation payment unit of the health-promoting entities in Colombia between 2017 and 2021: a financial–actuarial approach
Oscar Espinosa, Jhonathan Rodríguez, B. Piedad Urdinola, Pedro Luis Do Nascimento Silva, Alejandra Sánchez, Martha-Liliana Arias, Emiliano A. Valdez, Terence Cheng, Sara-Ellison Fisher
Correction to: Operative vs. conservative treatment of AC-Joint Dislocations Rockwood grade ≥ III -An economical and clinical evaluation-
Richard Niehaus, Alisa Schleicher, Ammann Elias, Philipp Kriechling, Christopher G. Lenz, Michael Masanneck, Sandro Hodel, Karim Eid
The use of cost-effectiveness analysis for health benefit package design – should countries follow a sectoral, incremental or hybrid approach?
Rob Baltussen, Gavin Surgey, Anna Vassall, Ole F. Norheim, Kalipso Chalkidou, Sameen Siddiqi, Mojtaba Nouhi, Sitaporn Youngkong, Maarten Jansen, Leon Bijlmakers, Wija Oortwijn
Cost-effectiveness of left atrial appendage closure for stroke prevention in atrial fibrillation: a systematic review appraising the methodological quality
Sumudu A. Hewage, Rini Noviyani, David Brain, Pakhi Sharma, William Parsonage, Steven M. McPhail, Adrian Barnett, Sanjeewa Kularatna
Cost-effectiveness analysis of surgical proximal femur fracture prevention in elderly: a Markov cohort simulation model
Momin S. Alnemer, Konstantin E. Kotliar, Valentin Neuhaus, Hans-Christoph Pape, Bernhard D. Ciritsis
Should additional value elements be included in cost-effectiveness analysis in pharmacoeconomic evaluation: a novel commentary
Lihua Sun, Shiqi Li, Xiaochen Peng
Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method
Qian Peng, Yue Yin, Min Liang, Mingye Zhao, Taihang Shao, Yaqian Tang, Zhiqing Mei, Hao Li, Wenxi Tang
Economic evaluation of dialysis and comprehensive conservative care for chronic kidney disease using the ICECAP-O and EQ-5D-5L; a comparison of evaluation instruments
Telma Zahirian Moghadam, Jane Powell, Afshan Sharghi, Hamed Zandian
Cost-effectiveness analysis of digital therapeutics for home-based cardiac rehabilitation for patients with chronic heart failure: model development and data analysis
Tianyi Liu, Yiyang Zhan, Silei Chen, Wenhong Zhang, Jian Jia
The application of artificial intelligence in health financing: a scoping review
Maryam Ramezani, Amirhossein Takian, Ahad Bakhtiari, Hamid R. Rabiee, Ali Akbar Fazaeli, Saharnaz Sazgarnejad
Financial burden of prostate cancer in the Iranian population: a cost of illness and financial risk protection analysis
Farbod Alinezhad, Farhad Khalili, Hossein Zare, Chunling Lu, Zahra Mahmoudi, Mahmood Yousefi
Cost-effectiveness analysis of isolation strategies for asymptomatic and mild symptom COVID-19 patients
Unyaporn Suthutvoravut, Patratorn Kunakorntham, Anchisatha Semayai, Amarit Tansawet, Oraluck Pattanaprateep, Pongsathorn Piebpien, Pawin Numthavaj, Ammarin Thakkinstian, Pongsakorn Atiksawedparit
In situ breast cancer surgeries in Sweden: lumpectomy or mastectomy?—a cost-effectiveness analysis over a 30-Year period using Markov model
Phu Duy Pham, Muchandifunga Trust Muchadeyi, Lars Lindholm
Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value
Piers Gillett, Robert K Mahar, Nancy R Tran, Mark Rosenthal, Maarten IJzerman
Cost-effectiveness of implant movement analysis in aseptic loosening after hip replacement: a health-economic model
Davide Lovera, Olof Sandberg, Maziar Mohaddes, Hanna Gyllensten
Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening
Hiro Farabi, Najmeh Moradi, Aziz Ahmadzadeh, Seyed Mohammad Kazem Agamir, Abdolreza Mohammadi, Aziz Rezapour
Health system productivity in sub-Saharan Africa: tuberculosis control in high burden countries
Esso-Hanam Atake
Cost-effectiveness of abemaciclib plus endocrine therapy in high-risk HR+/HER2–early breast cancer in China
Qiran Wei, YuTing Xu, Wei Liu, Xin Guan
A systematic literature review on direct and indirect costs of triple-negative breast cancer
Sadeq Rezaei, Majid Babaei
Methodology and results of cost-effectiveness of LDL-C lowering with evolocumab in patients with acute myocardial infarction in China
Yuansheng Wan, Jinyu Liu, Xiaolian Zhan, Yu Zhang, Ruxu You
Cost analysis of the management of end-stage renal disease patients in Abuja, Nigeria
Yakubu Adole Agada-Amade, Daniel Chukwuemeka Ogbuabor, Ejemai Eboreime, Obinna Emmanuel Onwujekwe
Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia
Yazed AlRuthia, Almaha H. Alfakhri, Ibtisam Alharbi, Fadi Ali Alghamdi, Miteb A. Alanazi, Abdullah Abdulrahman Alrabiah, Anwar Abdulrazzag Alsouan, Abdulrahman Abdullah Alshaikh, Majed Ali Almasaoud
Resource allocation in public sector programmes: does the value of a life differ between governmental departments?
Patricia Cubi-Molla, David Mott, Nadine Henderson, Bernarda Zamora, Mendel Grobler, Martina Garau
Population ageing and sustainability of healthcare financing in China
Wenqing Wu, Shujie Long, Arcadio A. Cerda, Leidy Y. Garcia, Mihajlo Jakovljevic